1. Garo B, Garré M, Quiot JJ, Boles JM, Becq-Giraudon B, Chennebault JM, et al. Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases. Presse Med. 1988; 17:1475–1478.
2. Marrie TJ.
Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med. 1993; 153:488–494.
Article
3. Yoshida T, Asato Y, Kukita I, Ooshiro M, Takara I, Iha H, et al. A 7-year-old boy with mycoplasmal infection requiring extracorporeal membrane oxygenation. Eur J Pediatr. 2003; 162:44–46.
Article
4. Van Bever HP, Van Doorn JW, Demey HE. Adult respiratory distress syndrome associated with
Mycoplasma pneumoniae infection. Eur J Pediatr. 1992; 151:227–228.
Article
5. Kwon JE, Ahn KY, Choi BS. Two patients with
Mycoplasma pneumoniae pneumonia progressing to acute respiratory distress syndrome. Allergy Asthma Respir Dis. 2017; 5:169–174.
Article
6. Park SJ, Pai KS, Kim AR, Lee JH, Shin JI, Lee SY. Fulminant and fatal multiple organ failure in a 12-year-old boy with
Mycoplasma pneumoniae infection. Allergy Asthma Immunol Res. 2012; 4:55–57.
Article
7. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis. 1980; 122:491–496.
8. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med. 1995; 162:133–142.
9. Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, et al. Clinical features of severe
Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007; 56:1625–1629.
Article
10. Noriega ER, Simberkoff MS, Gilroy FJ, Rahal JJ Jr. Life-threatening Mycoplasma pneumoniae pneumonia. JAMA. 1974; 229:1471–1472.
11. Izumikawa K, Izumikawa K, Takazono T, Kosai K, Morinaga Y, Nakamura S, et al. Clinical features, risk factors and treatment of fulminant
Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. J Infect Chemother. 2014; 20:181–185.
Article
12. Chung EH. Serological diagnosis of
Mycoplasma pneumoniae infections. Korean J Pediatr Infect Dis. 2006; 13:21–30.
Article
13. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by
Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis. 2000; 31:1507–1511.
Article
14. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe
Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2006; 41:263–268.
Article
15. Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental
Mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008; 198:1180–1188.
Article
16. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998; 280:159–165.
Article
17. Priestley MA, Helfaer MA. Approaches in the management of acute respiratory failure in children. Curr Opin Pediatr. 2004; 16:293–298.
Article
18. Meuers KV, Lally KP, Peek G, Zwischenberger JB. ECMO: extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor, Michigan: Extracorporeal Life Support Organization;2005.
19. Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med. 1996; 24:323–329.
Article
20. Park JM. Continuous renal replacement therapy in children. J Korean Soc Pediatr Nephrol. 2009; 13:118–129.
Article
21. Paden ML, Warshaw BL, Heard ML, Fortenberry JD. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011; 12:153–158.
Article
22. Mansel JK, Rosenow EC 3rd, Smith TF, Martin JW Jr. Mycoplasma pneumoniae pneumonia. Chest. 1989; 95:639–646.
23. Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics. 2000; 105:372–378.
Article